Partners Innovation Fund
46
25M
28
2.71
3
0.39
12
- Stages of investment
- Areas of investment
Summary
Partners Innovation Fund is the famous VC, which was founded in 2007. The venture was found in North America in United States. The main department of described VC is located in the Boston.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Syntimmune, lifeIMAGE, Daktari Diagnostics. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Health Diagnostics.
Speaking about the real fund results, this VC is 10 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Partners Innovation Fund performs on 1 percentage points less the average number of lead investments. The fund is constantly included in 2-6 investment rounds annually. The higher amount of exits for fund were in 2018. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Besides them, we counted 9 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Partners Innovation Fund, startups are often financed by Atlas Venture, Baxalta Ventures, Apple Tree Partners. The meaningful sponsors for the fund in investment in the same round are Atlas Venture, SR One, Baxalta Ventures. In the next rounds fund is usually obtained by Atlas Venture, SR One, Omega Funds.
Investments analytics
Analytics
- Total investments
- 46
- Lead investments
- 3
- Exits
- 12
- Rounds per year
- 2.71
- Follow on index
- 0.39
- Investments by industry
- Biotechnology (38)
- Health Care (30)
- Therapeutics (19)
- Medical (16)
- Pharmaceutical (13) Show 15 more
- Investments by region
-
- United States (44)
- France (2)
- Peak activity year
- 2019
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 43M
- Group Appearance index
- 0.96
- Avg. company exit year
- 6
- Avg. multiplicator
- 4.88
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Akouos | 01 Aug 2018 | Biotechnology, Health Diagnostics, Pharmaceutical | Early Stage Venture | 50M | United States, Massachusetts, Boston |
| Amolyt Pharma | 31 Jul 2019 | Health Care, Medical, Therapeutics | Early Stage Venture | 79M | Rhone-Alpes, Écully, France |
| Healthlane | 17 Mar 2020 | Software, Health Care, Medical | Seed | 150K | Lagos, Lagos, Nigeria |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.